Analgesia Comparison of Nalbuphine and Morphine for Laparoscopic Myomectomy
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 80
- 试验地点
- 1
- 主要终点
- numerical rating scale
研究概览
简要总结
to compare the analgesia and side effect of nalbuphine and morphine for elective Laparoscopic myomectomy.
详细描述
To compare the analgesia and side effect of nalbuphine and morphine for elective Laparoscopic myomectomy, by using patient controlled analgesia postoperatively, a randomized, double blind clinical trial. Patients undergoing elective Laparoscopic myomectomy are randomly divided into two groups: nalbuphine and morphine groups. All patients are under general anesthesia with routine methods. The nalbuphine group receive postoperative patient controlled analgesia using nalbuphine 30mg/120ml, while the morphine group receive postoperative patient controlled analgesia using morphine 60mg/120ml. Perioperative parameters are to be collected to compare the two groups.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Triple (Participant, Care Provider, Investigator)
盲法说明
double blind
入排标准
- 年龄范围
- 18 Years 至 80 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •elective Laparoscopic myomectomy patients 24hr post-operative patient controlled analgesia analgesia no mild or severe liver or renal disfunction
排除标准
- •can't understand patient controlled analgesia device refuse trial
研究组 & 干预措施
nalbuphine
using nalbuphine for patient controlled analgesia
干预措施: Nalbuphine (Drug)
morphine
using morphine for patient controlled analgesia
干预措施: Morphine (Drug)
结局指标
主要结局
numerical rating scale
时间窗: 24 hr post-operatively
1-10
次要结局
未报告次要终点
研究者
Yan Zhou, MD
MD
Peking University First Hospital